Top News
ADC Therapeutics: First advanced solid tumor patient dosed in Phase I clinical trial
SBA Member, 16.01.2019
InterAx Biotech closes financing round of CHF 3 million and appoints new member of the board
SBA Member, 15.01.2019
BC Platforms and MedEngine launch new models for global medical data science services
SBA Member, 15.01.2019
Basilea reports positive interim results from phase II study with oncology drug candidate
SBA Member, 09.01.2019
Bristol-Myers Squibb to acquire Celgene to create a premier innovative biopharma company
Switzerland, 07.01.2019
Oculis expands portfolio by In-licensing novel anti-TNF alpha antibody fragment from Novartis and raises CHF 15.5 million in financing round
SBA Member, 04.01.2019
Supported by:
